We are live on ! Find out more
CCRN icon

Cross Country Healthcare

144 hedge funds and large institutions have $440M invested in Cross Country Healthcare in 2017 Q4 according to their latest regulatory filings, with 19 funds opening new positions, 48 increasing their positions, 53 reducing their positions, and 24 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% more funds holding in top 10

Funds holding in top 10: 12 (+1)

2.36% more ownership

Funds ownership: 92.05%94.41% (+2.4%)

9% less repeat investments, than reductions

Existing positions increased: 48 | Existing positions reduced: 53

4% less funds holding

Funds holding: 150144 (-6)

8% less capital invested

Capital invested by funds: $478M → $440M (-$38.1M)

15% less call options, than puts

Call options by funds: $1.27M | Put options by funds: $1.49M

21% less first-time investments, than exits

New positions opened: 19 | Existing positions closed: 24

Holders
144
Holders Change
-6
Holders Change %
-4%
% of All Funds
3.27%
Holding in Top 10
2
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+100%
% of All Funds
0.05%
New
19
Increased
48
Reduced
53
Closed
24
Calls
$1.27M
Puts
$1.49M
Net Calls
-$227K
Net Calls Change
-$219K
Name Holding Trade Value Shares
Change
Change in
Stake
Renaissance Technologies
101
Renaissance Technologies
New York
$156K +$161K +12,200 New
HCM
102
Highbridge Capital Management
New York
$155K -$213K -16,154 -57%
CCIA
103
Campbell & Co Investment Adviser
Maryland
$155K +$160K +12,133 New
MLICM
104
Metropolitan Life Insurance Company (MetLife)
New York
$151K -$174K -13,162 -53%
CCMH
105
Cornerstone Capital Management Holdings
New York
$145K -$1.31M -99,229 -90%
GC
106
Globeflex Capital
California
$145K
UBS AM
107
UBS AM
Illinois
$139K
SG Americas Securities
108
SG Americas Securities
New York
$127K -$340K -25,714 -72%
MSA
109
Mason Street Advisors
Wisconsin
$121K +$3.24K +245 +3%
UBS Group
110
UBS Group
Switzerland
$118K +$2.09K +158 +2%
MCIM
111
Meadow Creek Investment Management
Georgia
$99K +$27.9K +2,108 +37%
SOADOR
112
State of Alaska Department of Revenue
Alaska
$92K
EP
113
Elkfork Partners
Oregon
$82K +$22.9K +1,736 +37%
Royal Bank of Canada
114
Royal Bank of Canada
Ontario, Canada
$81K -$9.67M -732,020 -99%
SO
115
STRS Ohio
Ohio
$75K -$135K -10,200 -63%
Barclays
116
Barclays
United Kingdom
$72K +$59.1K +4,473 +391%
PAM
117
Panagora Asset Management
Massachusetts
$71K
Parallax Volatility Advisers
118
Parallax Volatility Advisers
California
$69K +$71.6K +5,418 New
GHCM
119
Glen Harbor Capital Management
California
$64K +$18K +1,364 +37%
TRCT
120
Tower Research Capital (TRC)
New York
$61K +$15.7K +1,186 +33%
PNC Financial Services Group
121
PNC Financial Services Group
Pennsylvania
$54K +$45.9K +3,474 +470%
RCM
122
Riverhead Capital Management
Delaware
$52K +$14.5K +1,100 +37%
NA
123
Neuburgh Advisers
California
$47K +$13.1K +992 +37%
AIP
124
Ameritas Investment Partners
Nebraska
$37K
FGC
125
Financial Gravity Companies
Texas
$37K +$34.8K +2,634 New

CCRN Hedge Fund Activity: Q4 2017 in Review

144 of the 4,409 institutional investors tracked by Wall St. Rank reported a position in Cross Country Healthcare (CCRN) for Q4 2017, worth a combined $440M — down 8% from $478M a quarter earlier.

Sellers outnumbered buyers: 24 funds closed out of CCRN and 19 opened new positions — a net loss of 5 holders — while 53 trimmed existing stakes and 48 added.

The largest buyer was Benefit Street Partners, opening a new position worth an estimated $20.4M. The largest seller was Royal Bank of Canada, cutting an estimated $9.67M.

  • 144 institutional investors held Cross Country Healthcare (CCRN) as of Q4 2017, down from 150 in Q3 2017.
  • Funds reported $440M of Cross Country Healthcare stock for Q4 2017, down 8% quarter-over-quarter.
  • 19 funds opened new Cross Country Healthcare positions in Q4 2017 and 24 closed out, a net change of -5 holders.
  • The largest Cross Country Healthcare buyer in Q4 2017 was Benefit Street Partners, an estimated $20.4M added.
  • The largest Cross Country Healthcare seller in Q4 2017 was Royal Bank of Canada, an estimated $9.67M sold.

Based on aggregated 13F filings for Q4 2017.